1. Home
  2. OPTX vs CGTX Comparison

OPTX vs CGTX Comparison

Compare OPTX & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Syntec Optics Holdings Inc.

OPTX

Syntec Optics Holdings Inc.

N/A

Current Price

$7.10

Market Cap

295.4M

Sector

Finance

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

N/A

Current Price

$1.08

Market Cap

94.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPTX
CGTX
Founded
1981
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.4M
94.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OPTX
CGTX
Price
$7.10
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
587.5K
637.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.22
52 Week High
$9.15
$3.83

Technical Indicators

Market Signals
Indicator
OPTX
CGTX
Relative Strength Index (RSI) 55.18 44.15
Support Level $1.32 $1.00
Resistance Level $9.15 $1.19
Average True Range (ATR) 0.86 0.07
MACD -0.07 0.01
Stochastic Oscillator 65.91 34.29

Price Performance

Historical Comparison
OPTX
CGTX

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: